Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 Jan;5(1):3-5.
doi: 10.1242/dmm.009258.

The NIH Undiagnosed Diseases Program: bonding scientists and clinicians

William A Gahl, Cornelius F Boerkoel, Manfred Boehm
Editorial

The NIH Undiagnosed Diseases Program: bonding scientists and clinicians

William A Gahl et al. Dis Model Mech. 2012 Jan.

Abstract

The majority of the biomedical research workforce and funds are focused on studying common diseases and the development of drugs to treat them. However, some of the most remarkable discoveries in physiology and medicine are uncovered by studying rare conditions, because the importance of certain molecular mechanisms is revealed only when their dysfunction results in disease. In 2008, the National Institutes of Health (NIH) launched the NIH Undiagnosed Diseases Program (UDP), which recruits and selects patients who suffer from diseases of unknown etiology, and studies their causes at the clinical, genetic and cellular levels. In this Editorial, we discuss how the UDP has enabled the discovery of several new diseases and disease mechanisms through collaborations between clinical and basic science teams, using the power of both clinical medicine and biological models. Establishing programs with similar infrastructure at other centers around the world could help to benefit patients, their families and the entire medical community, by enhancing research productivity for rare and novel diseases.

PubMed Disclaimer

References

    1. Atorino L., Silvestri L., Koppen M., Cassina L., Ballabio A., Marconi R., Langer T., Casari G. (2003). Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J. Cell Biol. 163, 777–787 - PMC - PubMed
    1. De Praeter C. M., Gerwig G. J., Bause E., Nuytinck L. K., Vliegenthart J. F. G., Breuer W., Kamerling J. P., Espeel M. F., Martin J. J, De Paepe A. M., et al. (2000). A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. Am. J. Hum. Genet. 66, 1744–1756 - PMC - PubMed
    1. Gahl W. A., Tifft C. J. (2011). The NIH Undiagnosed Diseases Program: lessons learned. JAMA 305, 1904–1905 - PubMed
    1. Gahl W. A., Markello T. C., Toro C., Fuentes Fajardo K., Sincan M., Gill F., Carlson-Donohoe H., Gropman A., Pierson T. M., Golas G., et al. (2011). The NIH Undiagnosed Diseases Program: insights into rare diseases. Genet. Medicine (in press). - PMC - PubMed
    1. Koppen M., Metodiev M. D., Casari G., Rugarli E. I., Langer T. (2007). Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia. Mol. Cell. Biol. 27, 758–767 - PMC - PubMed

Publication types